↓ Skip to main content

Sphingolipids in Disease

Overview of attention for book
Cover of 'Sphingolipids in Disease'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Sphingosine Kinase/Sphingosine 1-Phosphate Signaling in Cancer Therapeutics and Drug Resistance
  3. Altmetric Badge
    Chapter 2 Using ASMase Knockout Mice to Model Human Diseases
  4. Altmetric Badge
    Chapter 3 Sphingolipids in Disease
  5. Altmetric Badge
    Chapter 4 Sphingolipids and Response to Chemotherapy
  6. Altmetric Badge
    Chapter 5 Lung Cancer and Lung Injury: The Dual Role of Ceramide
  7. Altmetric Badge
    Chapter 6 Sphingolipids' role in radiotherapy for prostate cancer.
  8. Altmetric Badge
    Chapter 7 Sphingolipid Metabolism and Atherosclerosis
  9. Altmetric Badge
    Chapter 8 Cardiovascular Effects of Sphingosine-1-Phosphate (S1P)
  10. Altmetric Badge
    Chapter 9 Cross Talk Between Ceramide and Redox Signaling: Implications for Endothelial Dysfunction and Renal Disease
  11. Altmetric Badge
    Chapter 10 Sphingolipids in Lung Endothelial Biology and Regulation of Vascular Integrity
  12. Altmetric Badge
    Chapter 11 Sphingolipids in Acute Lung Injury
  13. Altmetric Badge
    Chapter 12 The Involvement of Sphingolipids in Chronic Obstructive Pulmonary Diseases
  14. Altmetric Badge
    Chapter 13 Ceramide in cystic fibrosis.
  15. Altmetric Badge
    Chapter 14 Regulation of the sphingosine kinase/sphingosine 1-phosphate pathway.
  16. Altmetric Badge
    Chapter 15 Bacterial Infections and Ceramide
  17. Altmetric Badge
    Chapter 16 Viral Infections and Sphingolipids
  18. Altmetric Badge
    Chapter 17 Ceramide in Plasma Membrane Repair
  19. Altmetric Badge
    Chapter 18 Sphingolipids and Inflammatory Diseases of the Skin
  20. Altmetric Badge
    Chapter 19 Sphingolipids in Obesity, Type 2 Diabetes, and Metabolic Disease
  21. Altmetric Badge
    Chapter 20 Neuronal Forms of Gaucher Disease
  22. Altmetric Badge
    Chapter 21 Sphingolipids in Neuroinflammation
  23. Altmetric Badge
    Chapter 22 Sphingolipids in Psychiatric Disorders and Pain Syndromes
  24. Altmetric Badge
    Chapter 23 Role of Sphingosine 1-Phosphate in Skeletal Muscle Cell Biology
Attention for Chapter 6: Sphingolipids' role in radiotherapy for prostate cancer.
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Sphingolipids' role in radiotherapy for prostate cancer.
Chapter number 6
Book title
Sphingolipids in Disease
Published in
Handbook of experimental pharmacology, January 2013
DOI 10.1007/978-3-7091-1511-4_6
Pubmed ID
Book ISBNs
978-3-70-911510-7, 978-3-70-911511-4
Authors

Carla Hajj, Adriana Haimovitz-Friedman, Hajj, Carla, Haimovitz-Friedman, Adriana

Abstract

There are several well-established mechanisms involved in radiation-induced cell death in mammalian cell systems. The p53-mediated apoptotic pathway is the most widely recognized mechanism (Lowe et al. Nature 362:847-849, 1993), although apoptosis has long been considered a less relevant mechanism of radiation-induced cell death (Steel, Acta Oncol 40:968-975, 2001; Brown and Wouters, Cancer Res 59:1391-1399, 1999; Olive and Durand, Int J Radiat Biol 71:695-707, 1997). We and others have recently focused instead on the emerging links between radiation, apoptosis, and ceramide and showed that ceramide is a sphingolipid-derived second messenger capable of initiating apoptotic cascades in response to various stress stimuli, including radiation.Ceramide, the backbone of all sphingolipids, is synthesized by a family of ceramide synthases (CerS), each using acyl-CoAs of defined chain length for N-acylation of the sphingoid long-chain base. Six mammalian CerS homologs have been cloned that demonstrated high selectivity towards acyl-CoAs (Lahiri et al. FEBS Lett 581:5289-5294, 2007), and more recently, it was shown that their activity can be modulated by dimer formation (Mesicek et al. Cell Signal 22:1300-1307, 2010; Laviad et al. J Biol Chem 283:5677-5684, 2008).This de novo ceramide synthesis has been observed in irradiated cells through a pathway normally suppressed by ataxia telangiectasia-mutated (ATM) protein, a key component of the cellular response to DNA double-strand breaks (Liao et al. J Biol Chem 274:17908-17917, 1999). ATM is not the sole factor known to affect apoptotic potential by modulating CerS activity. Recent work has also implicated protein kinase Cα (PKCα) as a potential CerS activator (Truman et al. Cancer Biol Ther 8:54-63, 2009).In this review, we summarize involvement of CerS in sphingolipid-mediated apoptosis in irradiated human prostate cancer cells and discuss future directions in this field.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 8%
Unknown 12 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 23%
Student > Bachelor 2 15%
Professor > Associate Professor 2 15%
Professor 2 15%
Unspecified 1 8%
Other 2 15%
Unknown 1 8%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 31%
Unspecified 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Computer Science 1 8%
Immunology and Microbiology 1 8%
Other 2 15%
Unknown 3 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2013.
All research outputs
#18,335,133
of 22,705,019 outputs
Outputs from Handbook of experimental pharmacology
#499
of 644 outputs
Outputs of similar age
#218,006
of 280,712 outputs
Outputs of similar age from Handbook of experimental pharmacology
#7
of 8 outputs
Altmetric has tracked 22,705,019 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 644 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,712 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one.